Effect of Cytomegalovirus Reactivation on Inflammatory Status and Mortality of Older COVID-19 Patients
Authors:
- Robertina GiacconiRGRobertina Giacconi
- Maurizio CardelliMCMaurizio Cardelli
- Francesco PiacenzaFPFrancesco Piacenza
- Elisa PierpaoliEPElisa Pierpaoli
- Elisabetta FarnocchiaEFElisabetta Farnocchia
- MirKo Di RosaMirKo Di Rosa
- Anna Rita BonfigliABAnna Rita Bonfigli
- Tiziana CasoliTCTiziana Casoli
- Francesca MarchegianiFMFrancesca Marchegiani
- Fiorella MarcheselliFMFiorella Marcheselli
- Rina RecchioniRRRina Recchioni
- Pierpaolo StripoliPSPierpaolo Stripoli
Open Access
- 6 April 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (7) , 6832
Abstract
Herpesviridae reactivation such as cytomegalovirus (CMV) has been described in severe COVID-19 (COronaVIrusDisease-2019). This study aimed to understand if CMV reactivation in older COVID-19 patients is associated with increased inflammation and in-hospital mortality. In an observational single-center cohort study, 156 geriatric COVID-19 patients were screened for CMV reactivation by RT-PCR. Participants underwent a comprehensive clinical investigation that included medical history, functional evaluation, laboratory tests and cytokine assays (TNF-α, IFN-α, IL-6, IL-10) at hospital admission. In 19 (12.2%) of 156 COVID-19 patients, CMV reactivation was detected. Multivariate Cox regression models showed that in-hospital mortality significantly increased among CMV positive patients younger than 87 years (HR: 9.94, 95% CI: 1.66–59.50). Other factors associated with in-hospital mortality were C-reactive protein (HR: 1.17, 95% CI: 1.05–1.30), neutrophil count (HR: 1.20, 95% CI: 1.01–1.42) and clinical frailty scale (HR:1.54, 95% CI: 1.04–2.28). In patients older than 87 years, neutrophil count (HR: 1.13, 95% CI: 1.05–1.21) and age (HR: 1.15, 95% CI: 1.01–1.31) were independently associated with in-hospital mortality. CMV reactivation was also correlated with increased IFN-α and TNF-α serum levels, but not with IL-6 and IL-10 serum changes. In conclusion, CMV reactivation was an independent risk factor for in-hospital mortality in COVID-19 patients younger than 87 years old, but not in nonagenarians.Keywords
Funding Information
- Italian Health Ministry (Ricerca Corrente to IRCCS INRCA)
- Marche Region
This publication has 49 references indexed in Scilit:
- Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndromeIntensive Care Medicine, 2016
- CMV seropositivity and T‐cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ studyAging Cell, 2015
- Type I Interferon Released by Myeloid Dendritic Cells Reversibly Impairs Cytomegalovirus Replication by Inhibiting Immediate Early Gene ExpressionJournal of Virology, 2015
- Human cytomegalovirus replication supported by virus-induced activation of CCL2–CCR2 interactionsBiochemical and Biophysical Research Communications, 2014
- Chronic CMV infection in older women: Longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8+ T-cell frequencies with twelve year follow-upExperimental Gerontology, 2014
- Human memory T cells: generation, compartmentalization and homeostasisNature Reviews Immunology, 2013
- HCMV-Encoded UL128 Enhances TNF-α and IL-6 Expression and Promotes PBMC Proliferation Through the MAPK/ERK Pathway In VitroViral Immunology, 2012
- Longitudinal Studies of Clonally Expanded CD8 T Cells Reveal a Repertoire Shrinkage Predicting Mortality and an Increased Number of Dysfunctional Cytomegalovirus-Specific T Cells in the Very ElderlyThe Journal of Immunology, 2006
- A global clinical measure of fitness and frailty in elderly peopleCanadian Medical Association Journal, 2005
- Long-Term Cytomegalovirus Infection Leads to Significant Changes in the Composition of the CD8+T-Cell Repertoire, Which May Be the Basis for an Imbalance in the Cytokine Production Profile in Elderly PersonsJournal of Virology, 2005